Sudeep Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 1, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	83,825	66,928	-	-	-	-
Enterprise Value	84,330	67,823	-	-	-	-
Last Close Price	742.15	592.55	-	-	-	-
PE Ratio	47.88	38.71	-	-	-	-
Forward PE	43.40	35.53	-	-	-	-
PS Ratio	13.05	10.42	-	-	-	-
PB Ratio	9.33	7.45	-	-	-	-
P/TBV Ratio	10.37	8.28	-	-	-	-
P/OCF Ratio	120.52	96.23	-	-	-	-
PEG Ratio	3.65	3.01	-	-	-	-
EV/Sales Ratio	13.13	10.56	-	-	-	-
EV/EBITDA Ratio	38.00	30.56	-	-	-	-
EV/EBIT Ratio	40.72	32.75	-	-	-	-
Debt / Equity Ratio	0.17	0.17	0.28	0.22	0.37	0.52
Debt / EBITDA Ratio	0.68	0.68	0.72	0.43	0.93	1.23
Debt / FCF Ratio	-	-	-	5.01	66.90	-
Net Debt / Equity Ratio	0.04	0.04	0.17	0.18	0.31	0.39
Net Debt / EBITDA Ratio	0.16	0.16	0.45	0.36	0.79	0.92
Net Debt / FCF Ratio	-2.26	-2.26	-5.52	4.12	56.16	-1.05
Asset Turnover	0.68	0.68	0.82	0.98	1.12	-
Inventory Turnover	1.32	1.32	1.72	2.44	3.47	-
Quick Ratio	1.69	1.69	1.54	1.33	0.81	0.94
Current Ratio	3.09	3.09	2.43	2.01	1.35	1.33
Return on Equity (ROE)	25.05%	25.05%	32.68%	45.99%	32.28%	-
Return on Assets (ROA)	13.68%	13.68%	18.22%	23.15%	13.28%	-
Return on Invested Capital (ROIC)	18.11%	20.93%	27.24%	36.93%	22.70%	40.41%
Return on Capital Employed (ROCE)	21.30%	21.30%	33.10%	45.90%	32.60%	32.40%
Earnings Yield	2.06%	2.58%	-	-	-	-
FCF Yield	-0.19%	-0.24%	-	-	-	-
Dividend Yield	0.20%	0.25%	-	-	-	-
Buyback Yield / Dilution	-2.80%	-2.80%	-	-	-	-361.48%
Total Shareholder Return	-2.60%	-2.55%	-	-	-	-361.48%